{"id":772,"date":"2015-01-11T17:46:01","date_gmt":"2015-01-11T05:46:01","guid":{"rendered":"http:\/\/4abettermemory.com\/memory\/?p=772"},"modified":"2015-01-11T19:53:31","modified_gmt":"2015-01-11T07:53:31","slug":"alzheimers-prevention-new-hope-rising","status":"publish","type":"post","link":"https:\/\/4abettermemory.com\/memory\/alzheimers-prevention-new-hope-rising\/","title":{"rendered":"Alzheimer’s Prevention – New Hope Rising!"},"content":{"rendered":"

Prior to 2014 the official position was that Alzheimer’s disease (AD) and most other forms of dementia, and related symptoms, could not be prevented or reversed. But in 2014 and last week this gloomy picture was dispelled with the following revelations, the most compelling of which just appeared last week \u00a0in the\u00a0<\/span>Journal of Alzheimer’s Disease.<\/i><\/strong>\u00a0<\/i><\/b>(see details and link below in this article)<\/em><\/p>\n

The Karolinska\/FINGER Preliminary Findings<\/strong><\/span><\/p>\n

In my August Newsletter<\/strong> <\/a>I reported on the July International Conference on Alzheimer\u2019s Disease in Stockholm. At that conference Dr. Miia Kivipelto from the Karolinska Institute in Sweden electrified the crowd with her blockbuster report on the Finnish Geriatric (FINGER) Intervention Study to Prevent Cognitive Impairment and Disability. This ongoing study involves more than 1200 seniors at high risk for Alzheimer\u2019s. These participants were already experiening cognitive decline.<\/span><\/p>\n

The results of this large controlled study showed that improvements in lifestyle including physical and mental activities, a healthy diet and social support had a significant beneficial effect on the participant\u2019s cognitive performance. Not only was their decline arrested, in most of the study group it was actually reversed.<\/p>\n

In her presentation, Dr. Kivipelto stated, \u201cThese findings show that\u00a0<\/span>prevention is possible<\/strong>, and that it may be good to start early,\u201d noting that \u201cWith so many negative trials for Alzheimer\u2019s drugs reported lately, it\u2019s good that we may have something that everyone can do now to lower their risk.\u201d<\/span><\/p>\n

What was so impressive about this study was the fact that they didn\u2019t just improve health or reduce risk in healthy individuals, they actually reversed symptoms and effected improvements in individuals already in cognitive decline or well on their way to Alzheimer\u2019s.<\/p>\n

Korean Confirmation\u00a0<\/strong><\/span><\/p>\n

In late October an article that appeared in the journal Psychotherapy and Psychosomatics corroborated this finding in a similar elderly lifestyle study conducted in Korea. Once again those who improved their diet and lifestyle showed improved cognitive function, and thus reduced risk for dementia.<\/span><\/p>\n

But what about those already diagnosed with Alzheimer\u2019s? Is it too late for them, or is escape from death by Alzheimer\u2019s still possible at that stage?<\/span><\/p>\n

UCLA Study Astounds Skeptics<\/strong><\/span><\/p>\n

Before that in early \u00a0October we reported<\/strong><\/a> on a truly remarkable and encouraging paper published online in the new open access scientific journal AGING. This report described a \u201cnovel,\u201d personalized therapeutic program for individuals diagnosed with significant cognitive impairment or Alzheimer\u2019s. This treatment plan was developed by Dale E. Bredesen, MD at the MaryS.EastonCenter for Alzheimer\u2019s Disease Research at the University of California in Los Angeles. The protocol was based on what we know about the underlying causes of AD.<\/p>\n

Like the Korean and Finland (FINGER) study, it involved multiple modalities \u201cdesigned to achieve metabolic enhancement for neurodegeneration (MEND).\u201d In other words it was a multifaceted approach focused on addressing various factors affecting brain health. However, this program was more rigorous and including hormones, and specific nutritional interventions to address cell metabolism, circulation and inflammation, as well as meditation, Yoga and other brain stimulating activities \u2013 like daily reading.<\/span><\/p>\n

Dr. Bredesen notes that \u201dBased on the hypothesis that AD results from an imbalance in an extensive plasticity [ever changing] network, the therapy should address as many network components as possible, with the idea that a combination approach may create an effect that is more than the sum of the effects of many monotherapeutics.\u201d (A synergistic effect.) Dr. Bredesen identified at least 36 things that can be out of balance in Alzheimer\u2019s, but fortunately most of these can be rectified by simply applying what we already know.<\/span><\/p>\n

The point here is that there are many things that can go wrong and contribute to AD, and every \u201cbody\u201d is different. So, although most people with cognitive impairments have some things in common, a personalized program for each individual, focused on their particular issues and needs, will likely be best. At least that is the approach Dr. Bredesen took with the 10 participants in his study. And amazingly\u00a0<\/span>9 out of the 10 subjects<\/strong>\u00a0with significant cognitive impairments,<\/span>\u00a0<\/b>including several with diagnosed AD, improved<\/strong>! The only one who did not improve was in the later stages of Alzheimer\u2019s.<\/span><\/p>\n

Dr. Bredesen, being an MD, was able to employ a broader array of interventions than those used in the FINGER study, including medications and hormone replacement to address related disorders. But most of the interventions he used like dietary changes, yoga, meditation, periodic fasting, mental and physical exercise, as well as various nutritional supplements, are\u00a0<\/span>available to most anyone in the US without prescription.<\/strong><\/p>\n

The Joint International Review of AD Research<\/strong><\/span><\/p>\n

In October I also reported on an international investigation<\/a> conducted by some of the best and brightest Alzheimer\u2019s researchers in the world \u2013 from France, the Netherlands, and the United States. It was a massive review of more than 3000 studies from around the world.<\/p>\n

In short, what they found in this monumental review was that\u00a0<\/span>nutritional deficiencies play a major role<\/strong>\u00a0early on in the development of Alzheimer\u2019s. This was a major revelation to many, with huge implications for the prevention and management of Alzheimer\u2019s, as you will see below<\/span><\/p>\n

Moreover, contributing factors included not only what they ate, i.e. how nutritious the foods were that they ate, but\u00a0<\/span>how well they digested and absorbed the nutrients<\/strong>\u00a0from the foods they ate, as well as,\u00a0<\/span>changes in metabolism,<\/strong>\u00a0and nutrient\u00a0<\/span>depletion due to their body\u2019s \u201cincreased utilization of nutrients\u201d<\/strong>\u00a0needed to fight off the disease processes. So even if a person ate well, they could still end up with nutritional deficiencies, due to age, genetics and other unique biological factors exacerbated by aging.<\/span><\/p>\n

This then set the stage for what might be the most significant and hopeful study yet in the battle to prevent or arrest Alzheimer\u2019s disease.<\/span><\/p>\n

January 2015 \u2013 Even Greater Help and Hope<\/strong><\/span><\/p>\n

Finally on January 7th 2015 the Journal of Alzheimer\u2019s Disease offered online to subscribers, an advanced copy of our\u00a0UMass-Lowell study\u00a0<\/a><\/strong>on the effects of the NF (nutraceutical formulation now sold under the name Perceptiv\u2122 ) on 106 individuals with diagnosed Alzheimer\u2019s.1<\/p>\n

Unlike the UCLA project, this was not a pilot or preliminary study, but a “<\/span>gold standard,” double-blind, placebo-controlled, multi-site,<\/strong>\u00a0<\/span>phase II clinical study<\/strong><\/a>\u00a0of the effects of a nutritional supplement, containing a variety of vitamins and other nutrients, on mental abilities associated with Alzheimer’s. This was the\u00a0<\/span>sixth successful clinica<\/strong>l study with this formulation, which was developed over the past 20 years by Dr. Thomas Shea and colleagues at UMass-Lowell.<\/span><\/p>\n

Basically, the study showed\u00a0statistically-significant improvements or arrested decline<\/strong>\u00a0in memory and other cognitive abilities (as measured by live standardized tests) in subjects diagnosed with Alzheimer\u2019s who received the supplement, as compared to subjects who received a placebo.<\/p>\n

(If you would like an uncorrected pdf \u201cauthors\u201d copy email me at DavidRJL@aol.com (2) \u00a0But as of yet, while they are still charging for this, I am not allowed to post that here. Although you can purchase a copy online\u00a0<\/span>there<\/a>. But my copy is quite complete, with few alterations if you want to see the science and stats now.)<\/span><\/p>\n

Here are the outcome highlights.<\/p>\n

Figure 1
\n\"EPSON<\/a><\/p>\n

Results after 3 months. The Clox test measures spatial abilities, reasoning and memory. The DRS is the Dementia Rating Scale which measures a variety of mental abilities. The AMSS adjusts for age and the AEMSS for age and education level. The forth chart shows the memory subscale. The dark block is where most of the scores fell. The thin line shows the range from highest to the lowest in ea category.<\/p>\n

As you can see on each of the graphs, although the scores varied widely, after 3 months, the majority of those in the NF group, taking the Nutraceutical (nutritional)<\/span><\/p>\n

Formulation,\u00a0<\/b>performed significantly better<\/strong>\u00a0on these tests of attention, memory, reasoning, comprehension, etc., than those in the Placebo group, who took a pill that looked identical but did not contain these nutrients.<\/p>\n

Moreover, these were not individuals with just \u201cmild\u201d cognitive impairment. These graphs show the results, in terms of performance or ability, for those in our study who\u00a0<\/span>had MD diagnosed Alzheimer\u2019s<\/strong>. And of course what they show is that within 3 months this nutritional supplement made a significant difference in memory and other abilities for most (approximately 80%) of those who took it.<\/span><\/p>\n

This next graph shows the composite progress over time, as measured by the dementia rating scale. This is for all of those in our study, including both individuals with mild cognitive impairment, not yet diagnosed with dementia, as well as those with dementia or Alzheimer\u2019s. These were the results over a nine month period.<\/span><\/p>\n

Figure 2
\n\"1<\/a>
\n<\/span>While most participants in both groups showed some improvement at 3 months\u2014likely due to greater familiarity and reduced test anxiety\u2014there was a\u00a0<\/span>major difference in the magnitude of effect.<\/strong>\u00a0As noted above, nearly\u00a0<\/span>80% of those initially on the nutritional formulation showed improvements<\/strong>\u00a0compared to 53% in the placebo group, and their improvements were\u00a0<\/span>significantly greater<\/strong>\u00a0both in mood and memory, with no significant adverse side effects.<\/span><\/p>\n

After 3 months the institutional review board monitoring this study, decided we had made our point, reinforcing earlier studies that this formulation can make a significant difference, and therefore they felt it only ethical to allow those who had been in the control group to take it as well. That is what \u201copen label\u201d means. So after that everyone was taking NF (now sold as Perceptiv\u2122) and everyone knew what they were getting \u2013 i.e. the label matched the contents.<\/span><\/p>\n

Lessons Learned<\/strong><\/p>\n

There were many lessons learned from this study, however, there are three in particular that seem most relevant for our purposes that I would like to review with you. First…<\/p>\n

A Pill Alone May Not Be Enough<\/strong><\/span><\/p>\n

If you look carefully at the graphs above you will see the single lines extending below the black blocks. These represent those individuals who did not fare so well. These are the 20% or so who did not make much, if any progress, and were more likely to continued their downward spiral.<\/p>\n

Some of these improved after 3 months, other may have had strong genetic factors influencing their decline, such as the Apoe-4 \u201cAlzheimer\u2019s\u201d gene. We know that genetics and family history do play a significant role in many if not most cases of Alzheimer\u2019s. However,\u00a0others<\/strong>\u00a0in our study with a documented family history and\u00a0<\/b>likely genetic predisposition for Alzheimer\u2019s made great progress!<\/strong>\u00a0In fact Dr. Shea has shown in other animal studies that the NF formulation can, to a significant degree, help to\u00a0compensate for bad genes<\/strong>.<\/p>\n

Otherwise, it would be helpful to know why some did better on this formula than others, i.e what other factors made a difference here. Generally we did not track other lifestyle variables in this study, like diet, exercise etc., but Dr. Morrow and I did note a few of these from our conversations with family members.<\/p>\n

One of the first things we observed, was that those who\u00a0<\/span>did not eat a nutritious diet<\/strong>, who did not eat a variety of vegetables, for example,\u00a0<\/span>did not progress<\/strong>\u00a0as well as those who did. On the other hand those who consumed significant quantities of sugar, ice-cream, or other sweet treats, pastries or other high carb \u201cjunk food,\u201d did not progress as well as those who did not.<\/span><\/p>\n

Second, although these were not carefully measured, a few other apparent lifestyle deterrents to progress included,\u00a0<\/span>lack of physical or mental exercise, lack of water intake<\/strong>, often associated with a\u00a0<\/span>urinary tract infection,<\/strong>\u00a0and a\u00a0<\/span>lack of sleep or stress<\/strong>.<\/span><\/p>\n

Third, it was also interesting that a high percentage of those in our study were on a\u00a0<\/span>statin (cholesterol) or antacid<\/strong>\u00a0medication. Dr. Shea also observed in previous studies that those who did not do so well were generally older and took more medications than those who made better progress. Of course it\u2019s hard to say how much those contributed. Was it the medication or the disorder the medication was taken for. Actually Dr. Perlmutter suggests it could be both. But these seem worth considering, and we have written about those in other publications.<\/span><\/p>\n

The point I want to make here is that researchers are now coming to realize is that the only way to ensure a healthy brain and avoid the brain damaging plagues of our age is to\u00a0<\/span>develop a brain-healthy diet and lifestyle<\/strong>. And as we get older a good targeted higher potency<\/span>\u00a0<\/b>nutritional supplement<\/strong>\u00a0or two may be needed as well. That seems to be the only approach that can create a<\/span>\u00a0<\/b>synergistic effect<\/strong>\u00a0powerful enough to provide all that our body and brain need to succeed as we advance in years.<\/span><\/p>\n

The Sooner the Better<\/strong><\/span><\/p>\n

Previous studies have shown that the Alzheimer\u2019s disease process is generally on a very long continuum, that usually begins\u00a020 years or more before<\/strong>\u00a0significant symptoms arise or decline becomes apparent. And the earlier we address these deviant processes the easier they will be to overcome.\u00a0Therefore, as might be expected, the positive results in this study were more pronounced for those in the early to mid stages of Alzheimer\u2019s rather than the later stages.<\/p>\n

This also supports the findings of the International Review noted above, which suggesting that Alzheimer’s is associated with greater nutritional deficits as we age. And that nutrients may be harder to assimilate as we age, which emphasizes the importance of\u00a0<\/span>early nutritional interventions<\/strong>\u00a0to arrest or reverse symptom decline. Because the further down that road we allow ourselves to go, the harder or less likely it is that we will be able to regain full mental health and abilities.<\/span><\/p>\n

More than Symptom Relief<\/strong><\/span><\/p>\n

One of the limitations of this particular study was that, although we were able to show\u00a0<\/span>symptom reversal<\/strong>\u00a0in individuals diagnosed with Alzheimer\u2019s disease, our measures were not sufficient or appropriate to show disease remission. So we can not claim that this arrested or mitigated AD per se.<\/span><\/p>\n

However, towards the end of this report Dr. Shea note that while the \u201cclinical analyses were confined to symptomatic efficacy\u2026 preclinical studies demonstrate that components of [this formulation] support general nervous system health (e.g., reduced oxidative damage and homocysteine levels, increased glutathione levels and bioavailability, increased acetylcholine levels) and aspects of neuronal health\u00a0<\/span>directly related to dementia<\/strong>\u00a0(reduction of PS-1 expression, secretase activity, intracellular and extracellular\u00a0<\/span>Abeta deposits<\/strong>).\u201d<\/span><\/p>\n

He further notes “general beneficial effects of NF in preclinical studies may have\u00a0<\/span>alleviated AD-related neuropathology.<\/strong>\u00a0For example, oxidative stress is an early event in AD neuropathology, homocysteine augments amyloid induced oxidative\u00a0damage and is correlated with impaired executive function, reduced levels of glutathione potentiates neuronal oxidative damage, and reduced acetylcholine levels correlate with impaired cognitive performance.”<\/span><\/p>\n

Thus, he concludes, this formulation “may harbor\u00a0<\/span>disease-modifying properties if administered early enough*<\/strong>\u00a0as part of a\u00a0<\/span>preventative approach,<\/strong>” i.e. in conjunction with \u201ca healthy diet, and lifestyle, involving adequate physical activity, social interactions and cognitive stimulation.\u201d<\/span><\/p>\n

* at the onset of, or prior to, cognitive decline to maximize efficacy<\/span><\/p>\n

Would You Like To Try This?<\/strong><\/span><\/p>\n

If you would like to purchase a bottle of Perceptiv I have worked out a discount for you my readers. \u00a0Just click here<\/a>.\u00a0\u00a0Then arrow down to Perceptiv<\/strong> and click on the button that says ADD TO CART, and enter your information. \u00a0For larger quantity discounts email DavidRJL@aol.com . \u00a0Because I was one of the researchers I can give you a better price. \u00a0Or I can save you $ on their website at Perceptiv.com<\/a><\/strong>\u00a0Just click Buy Now. Select the option you prefer. Click on Add To Cart. Then in the space after \u00a0it says Enter coupon code put \u00a0UtahFS <\/strong>and click Update. You should then see that the $8.95 shipping cost below has been discounted as well so your final cost is the same as before shipping. \u00a0Those are good prices, but if you contact me I can still get you a bit better, plus personal advice on other options to make it more effective.<\/p>\n

Further Evidence Prevention is Possible<\/strong><\/p>\n

In addition to this study at least 6 other major studies have now shown symptom reduction in at risk seniors, even some at “high” risk. Instead of continuing their decline, they were able to improve their cognitive abilities– i.e. move in the opposite direction. All of which suggests that\u00a0indeed prevention is possible,<\/strong>\u00a0especially when these steps are taken before symptoms appear.<\/p>\n

For another review of the facts on this topic see my article\u00a0<\/span>Can Alzheimer’s Disease be Prevented or Arrested<\/i><\/strong>\u00a0<\/a>on the Website of the American Academy of Anti-Aging Medicine.<\/span><\/p>\n

http:\/\/www.antiagingage.com\/anti-aging-research-articles\/item\/can-alzheimers-disease-be-prevented-or-arrested<\/p>\n

New Hope Rising \u2013 Summary<\/strong><\/p>\n

Despite discouraging claims to the contrary, many researchers and practitioners have long declared that dementia prevention is possible, but until recently there had not been many studies robust enough to prove it. Nor did we know the full composition of the lifestyle that would be best for the brain. But now thanks to this recent research\u00a0<\/span>we do know a great deal about those details.<\/strong>\u00a0And we see from the studies reviewed here that indeed prevention appears to be possible! Hopefully, you will soon see this healthy lifestyle approach become the standard of practice in the US as well as Europe.<\/span><\/p>\n

We believe that by adopting a brain healthy lifestyle with some additional supplementation, a large percentage of our population living today will be spared the ravages of cognitive decline, and the plague of Alzheimer\u2019s may be reduced to a footnote in medical history books. But the evidence is clear,\u00a0<\/span>the earlier we start this the greater our chances<\/strong>\u00a0of arresting and reversing this destructive process.<\/span><\/p>\n

On a personal level, if you and your loved ones will adopt the brain healthy lifestyle advocated by the American Brain Councill and it\u2019s affiliates,\u00a0and stick with it<\/strong>, this research suggests you will enjoy a longer, healthier, and happier life!<\/p>\n

David R. Larsen, MFHD<\/span><\/p>\n

__________<\/p>\n

1. Remington et al., 2015, Journal of Alzheimer’s disease doi: 10.3233\/JAD-142499<\/span><\/p>\n

2. Email me at DavidRJL@aol.com for a copy of his summary of research on Perceptiv\u2019s epigenetic influence, also for more information about this formulation and where you can obtain it.<\/span><\/p>\n

\u00a0<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"

Prior to 2014 the official position was that Alzheimer’s disease (AD) and most other forms of dementia, and related symptoms, could not be prevented or reversed. But in 2014 and last week this gloomy picture was dispelled with the following revelations, the most compelling of which just appeared last week \u00a0in the\u00a0Journal of Alzheimer’s Disease.\u00a0(see […]<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[4],"tags":[],"class_list":["post-772","post","type-post","status-publish","format-standard","hentry","category-prevention-strategies"],"_links":{"self":[{"href":"https:\/\/4abettermemory.com\/memory\/wp-json\/wp\/v2\/posts\/772","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/4abettermemory.com\/memory\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/4abettermemory.com\/memory\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/4abettermemory.com\/memory\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/4abettermemory.com\/memory\/wp-json\/wp\/v2\/comments?post=772"}],"version-history":[{"count":10,"href":"https:\/\/4abettermemory.com\/memory\/wp-json\/wp\/v2\/posts\/772\/revisions"}],"predecessor-version":[{"id":786,"href":"https:\/\/4abettermemory.com\/memory\/wp-json\/wp\/v2\/posts\/772\/revisions\/786"}],"wp:attachment":[{"href":"https:\/\/4abettermemory.com\/memory\/wp-json\/wp\/v2\/media?parent=772"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/4abettermemory.com\/memory\/wp-json\/wp\/v2\/categories?post=772"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/4abettermemory.com\/memory\/wp-json\/wp\/v2\/tags?post=772"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}